NEW YORK, Jan. 15, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS), an emerging leader in the fast growing cell therapy market, announced today that Dr. Aaron Havens of the University of Michigan has won the Milo Hellman Research Award from the American Association of Orthodontists ("AAO") for his research in collaboration with NeoStem. The research, published in Stem Cells and Development in an article titled "Human Very Small Embryonic-Like Cells Generate Skeletal Structures, In Vivo," demonstrated bone regeneration capabilities of human VSELs™ stem cells in a mouse model, further expanding the therapeutic potential of NeoStem's proprietary regenerative cell therapy product.
NeoStem Announces Receipt Of Hellman Research Award By Academic Collaborator For VSEL(TM) Research
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.